# Safety and Long-term Evaluation (up to 5 Years) of First Booster Immunization With Novartis' TBE Vaccine for Adults in Adolescents and Adults

> **NCT00387634** · PHASE4 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 323 (actual)

## Conditions studied

- Tick Born Encephalitis

## Interventions

- **BIOLOGICAL:** TBE vaccine for adults

## Key facts

- **NCT ID:** NCT00387634
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 323 (ACTUAL)
- **Last updated:** 2012-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00387634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00387634, "Safety and Long-term Evaluation (up to 5 Years) of First Booster Immunization With Novartis' TBE Vaccine for Adults in Adolescents and Adults". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00387634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*